These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23672493)

  • 21. Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance.
    Okada T; El-Mehasseb IM; Kodaka M; Tomohiro T; Okamoto K; Okuno H
    J Med Chem; 2001 Dec; 44(26):4661-7. PubMed ID: 11741483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel 4-Amino-Quinazoline moieties ligated Platinum(IV) prodrugs overcome cisplatin resistance in EGFR
    Li R; Zhao W; Jin C; Xiong H
    Bioorg Chem; 2023 Jun; 135():106499. PubMed ID: 37058978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
    Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
    Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of chloroquine in combination with Cisplatin in human gastric cancer xenografts.
    Zhang HQ; Fang N; Liu XM; Xiong SP; Liao YQ; Jin WJ; Song RF; Wan YY
    Asian Pac J Cancer Prev; 2015; 16(9):3907-12. PubMed ID: 25987058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines.
    Mora-Lagos B; Cartas-Espinel I; Riquelme I; Parker AC; Piccolo SR; Viscarra T; Reyes ME; Zanella L; Buchegger K; Ili C; Brebi P
    PLoS One; 2020; 15(1):e0228331. PubMed ID: 31990955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
    Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
    Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
    Mao Z; Bian G; Sheng W; He S; Yang J; Dong X
    Oncol Rep; 2013 Nov; 30(5):2288-96. PubMed ID: 23982423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression.
    Sun G; Li Z; He Z; Wang W; Wang S; Zhang X; Cao J; Xu P; Wang H; Huang X; Xia Y; Lv J; Xuan Z; Jiang T; Fang L; Yang J; Zhang D; Xu H; Xu Z
    J Exp Clin Cancer Res; 2020 Nov; 39(1):246. PubMed ID: 33198772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SORL1 stabilizes ABCB1 to promote cisplatin resistance in ovarian cancer.
    Zheng Z; Li X; Yang B; Xu Q; Zhu X; Hu L; Teng Y
    Funct Integr Genomics; 2023 May; 23(2):147. PubMed ID: 37145301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly (γ, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: a comparative study with clinically used platinum derivatives.
    Feng Z; Lai Y; Ye H; Huang J; Xi XG; Wu Z
    Cancer Sci; 2010 Nov; 101(11):2476-82. PubMed ID: 20813014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway.
    Zhang Z; Yu X; Zhou B; Zhang J; Chang J
    Biomed Res Int; 2020; 2020():5103272. PubMed ID: 32855967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipose most abundant 2 protein is a predictive marker for cisplatin sensitivity in cancers.
    Kamimura K; Suda T; Fukuhara Y; Okuda S; Watanabe Y; Yokoo T; Osaki A; Waguri N; Ishikawa T; Sato T; Aoyagi Y; Takamura M; Wakai T; Terai S
    Sci Rep; 2021 Mar; 11(1):6255. PubMed ID: 33737617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.
    Cao HY; Xiao CH; Lu HJ; Yu HZ; Hong H; Guo CY; Yuan JF
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6478-6485. PubMed ID: 31378887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients.
    Nakamura M; Tsuji N; Asanuma K; Kobayashi D; Yagihashi A; Hirata K; Torigoe T; Sato N; Watanabe N
    Cancer Sci; 2004 Jan; 95(1):44-51. PubMed ID: 14720326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1.
    Wang Q; Wu J; Wei H; Huang H; Huang Y; Fang H; Gong X; Sun J; Wu Y; Lei C; Yu J; Hu D
    Int J Biochem Cell Biol; 2021 Sep; 138():106040. PubMed ID: 34246759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis.
    Zhang Q; Miao Y; Fu Q; Hu H; Chen H; Zeng A; Jin Y; Jiang Y; Qian L; Wu L; Xu L; Wang G; Qiu L; Huang X; Xia Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):713-720. PubMed ID: 32253030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1.
    Shang Y; Zhang Z; Liu Z; Feng B; Ren G; Li K; Zhou L; Sun Y; Li M; Zhou J; An Y; Wu K; Nie Y; Fan D
    Oncogene; 2014 Jun; 33(25):3267-76. PubMed ID: 23893241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.